This company listing is no longer active

This company may still be operating, however this listing is no longer active. Find out why through their latest events.

PLUN BTA Stock Overview

A medical technology company, develops, manufactures, and sells urological devices and treatments in Sweden and internationally. More details

PLUN BTA fundamental analysis
Snowflake Score
Valuation	0/6
Future Growth	0/6
Past Performance	0/6
Financial Health	3/6
Dividends	0/6

Risk Analysis

Has less than 1 year of cash runway

Shares are highly illiquid

Does not have meaningful revenue (SEK18M)

Does not have a meaningful market cap (SEK219M)

+ 1 more risk

Community vs My Fair Value

Create Narrative

Select a narrative for quick price alerts from the community, or create your own.

ProstaLund AB (publ) Competitors

Price History & Performance

Summary of share price highs, lows and changes for ProstaLund
Historical stock prices
Current Share Price	SEK 2.60
52 Week High	SEK 3.09
52 Week Low	SEK 1.71
Beta	1.02
1 Month Change	n/a
3 Month Change	n/a
1 Year Change	n/a
3 Year Change	n/a
5 Year Change	n/a
Change since IPO	37.57%

Recent updates

Shareholder Returns

	PLUN BTA	SE Medical Equipment	SE Market
7D	19.8%	0.6%	-1.7%
1Y	n/a	-12.6%	-3.1%

Return vs Industry: Insufficient data to determine how PLUN BTA performed against the Swedish Medical Equipment industry.

Return vs Market: Insufficient data to determine how PLUN BTA performed against the Swedish Market.

Price Volatility

Is PLUN BTA's price volatile compared to industry and market?
PLUN BTA volatility
PLUN BTA Average Weekly Movement	n/a
Medical Equipment Industry Average Movement	8.7%
Market Average Movement	6.9%
10% most volatile stocks in SE Market	13.5%
10% least volatile stocks in SE Market	4.3%

Stable Share Price: PLUN BTA's share price has been volatile over the past 3 months.

Volatility Over Time: Insufficient data to determine PLUN BTA's volatility change over the past year.

About the Company

Founded	Employees	CEO	Website
1991	9	Johan Wennerholm	prostalund.se

ProstaLund AB (publ), a medical technology company, develops, manufactures, and sells urological devices and treatments in Sweden and internationally. It offers CoreTherm, a heat treatment for benign prostate enlargement; CoreFlow soft stent; Oruflow, a urine flow meter; Dosi-Fuser, a disposable continuous infusion system; and Dosi-Flow, a gravitation unit with a flow regulator for dosing of medicines. The company also provides Schelin Catheter, an injection tool that allows the urologists to administer drugs into the prostate in a sterile way through the urethra.

ProstaLund AB (publ) Fundamentals Summary

How do ProstaLund's earnings and revenue compare to its market cap?
PLUN BTA fundamental statistics
Market cap	SEK 219.04m
Earnings (TTM)	-SEK 12.17m
Revenue (TTM)	SEK 18.43m

11.9x

P/S Ratio

-18.0x

P/E Ratio

Is PLUN BTA overvalued?

See Fair Value and valuation analysis

Earnings & Revenue

Key profitability statistics from the latest earnings report (TTM)
PLUN BTA income statement (TTM)
Revenue	SEK 18.43m
Cost of Revenue	SEK 5.47m
Gross Profit	SEK 12.96m
Other Expenses	SEK 25.13m
Earnings	-SEK 12.17m

Last Reported Earnings

Mar 31, 2023

Next Earnings Date

Jul 14, 2023

Earnings per share (EPS)	-0.16
Gross Margin	70.32%
Net Profit Margin	-66.06%
Debt/Equity Ratio	4.2%

How did PLUN BTA perform over the long term?

See historical performance and comparison

Company Analysis and Financial Data Status

Data	Last Updated (UTC time)
Company Analysis	2023/07/08 03:59
End of Day Share Price	2023/07/06 00:00
Earnings	2023/03/31
Annual Earnings	2022/12/31

Data Sources

The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.

Package	Data	Timeframe	Example US Source ^*
Company Financials	10 years	Income statement Cash flow statement Balance sheet	SEC Form 10-K SEC Form 10-Q
Analyst Consensus Estimates	+3 years	Forecast financials Analyst price targets	Analyst Research Reports Blue Matrix
Market Prices	30 years	Stock prices Dividends, Splits and Actions	ICE Market Data SEC Form S-1
Ownership	10 years	Top shareholders Insider trading	SEC Form 4 SEC Form 13D
Management	10 years	Leadership team Board of directors	SEC Form 10-K SEC Form DEF 14A
Key Developments	10 years	Company announcements	SEC Form 8-K

^* Example for US securities, for non-US equivalent regulatory forms and sources are used.

Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more.

Analysis Model and Snowflake

Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.

Learn about the world class team who designed and built the Simply Wall St analysis model.

Industry and Sector Metrics

Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on Github.

Analyst Sources

ProstaLund AB (publ) is covered by 1 analysts. of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.

Analyst	Institution
Markus Augustsson	Carlsquare AB

ProstaLund OM:PLUN BTA Stock Report